Population pharmacokinetics (PopPK) and exposure-response (ER) analyses to confirm the global alectinib (ALC) 600mg BID dose in the Chinese treatment-naïve population.
2018 ◽
Vol 36
(15_suppl)
◽
pp. e21133-e21133
2018 ◽
Vol 83
(2)
◽
pp. 319-328
◽
Keyword(s):
2008 ◽
Vol 48
(7)
◽
pp. 823-836
◽
2017 ◽
Vol 6
(5)
◽
pp. 340-349
◽
2014 ◽
Vol 70
(11)
◽
pp. 1339-1351
◽
Keyword(s):
2003 ◽
Vol 74
(6)
◽
pp. 569-580
◽
2016 ◽
Vol 77
(4)
◽
pp. 733-743
◽
2014 ◽
Vol 73
(4)
◽
pp. 737-747
◽